Interleukin 18 is a primary mediator of the inflammation associated with dextran sulphate sodium induced colitis: blocking interleukin 18 attenuates intestinal damage.
about
The IL-1 cytokine family and its role in inflammation and fibrosis in the lungInflammasomes and intestinal homeostasis: regulating and connecting infection, inflammation and the microbiotaAn NK Cell Perforin Response Elicited via IL-18 Controls Mucosal Inflammation Kinetics during Salmonella Gut InfectionEpithelial IL-18 Equilibrium Controls Barrier Function in Colitis.Pathophysiological roles for IL-18 in inflammatory arthritisIRAK-4 inhibitors for inflammationIL-22BP is regulated by the inflammasome and modulates tumorigenesis in the intestineNeutrophil chemokines and their role in IL-18-mediated increase in neutrophil O2- production and intestinal edema following alcohol intoxication and burn injuryAlteration in intestine tight junction protein phosphorylation and apoptosis is associated with increase in IL-18 levels following alcohol intoxication and burn injuryInflammatory bowel diseaseInterleukin-18.Potential of IL-1, IL-18 and Inflammasome Inhibition for the Treatment of Inflammatory Skin Diseases.Small molecule-driven mitophagy-mediated NLRP3 inflammasome inhibition is responsible for the prevention of colitis-associated cancerFree immunoglobulin light chain (FLC) promotes murine colitis and colitis-associated colon carcinogenesis by activating the inflammasome.Oral administration of high molecular weight hyaluronan (900 kDa) controls immune system via Toll-like receptor 4 in the intestinal epitheliumDeregulated inflammasome signaling in disease.Insights from advances in research of chemically induced experimental models of human inflammatory bowel disease.The NLRP3 inflammasome protects against loss of epithelial integrity and mortality during experimental colitis.Balance of meprin A and B in mice affects the progression of experimental inflammatory bowel disease.The Nlrp3 inflammasome: contributions to intestinal homeostasis.Mitochondria-targeted antioxidant MitoQ ameliorates experimental mouse colitis by suppressing NLRP3 inflammasome-mediated inflammatory cytokines.Decreased development of necrotizing enterocolitis in IL-18-deficient miceCaspase-11 attenuates gastrointestinal inflammation and experimental colitis pathogenesisNLRPs, microbiota, and gut homeostasis: unravelling the connection.A (99m)Tc-labeled dual-domain cytokine ligand for imaging of inflammation.Immune networks in animal models of inflammatory bowel disease.The NLRP1 inflammasome attenuates colitis and colitis-associated tumorigenesisEmerging significance of NLRs in inflammatory bowel disease.Experimental Models of Inflammatory Bowel Diseases.Discovery of 5-Amino-N-(1H-pyrazol-4-yl)pyrazolo[1,5-a]pyrimidine-3-carboxamide Inhibitors of IRAK4.Inflammasomes and Intestinal TumorigenesisUpdate on biologic pathways in inflammatory bowel disease and their therapeutic relevance.Identification of IL18RAP/IL18R1 and IL12B as leprosy risk genes demonstrates shared pathogenesis between inflammation and infectious diseasesAn angiotensin II receptor antagonist reduces inflammatory parameters in two models of colitis.Intestinal CD103(+)CD11b(-) dendritic cells restrain colitis via IFN-γ-induced anti-inflammatory response in epithelial cells.Genetic analysis of innate immunity in Crohn's disease and ulcerative colitis identifies two susceptibility loci harboring CARD9 and IL18RAP.Prointerleukin-18 is activated by meprin beta in vitro and in vivo in intestinal inflammation.Stimulatory and costimulatory effects of IL-18 directed to different small intestinal CD43 T cell subsetsOpposing Functions of Classic and Novel IL-1 Family Members in Gut Health and Disease.The role of pattern recognition receptors in intestinal inflammation.
P2860
Q26752849-3C7512E2-521F-426C-974D-68FF7583D52CQ27025039-D50B816A-6B96-4DD1-A898-4F2E5B3C3432Q27313075-6F30EECD-9EC9-4FC3-AB85-B530A445A6B2Q27321681-92171BF0-F8DF-469F-AE42-FA35D02A967FQ28187644-8B00FC61-4335-4614-BBBC-92C59A81296FQ28255508-9A6679AA-46C6-4672-8B8A-78227856F9F1Q28506198-8A3E1711-34E0-489A-B0F6-4941BA58B652Q28573787-D6D39439-444B-4A71-8BF1-76B71ACA0329Q28582407-51A1BB10-0424-4092-9831-9DA0721CF28BQ29615500-8ECB4CC6-AADB-446C-9E0C-4EF90F040A52Q30884172-00F725C4-1516-42F5-ACA8-5579371DF19EQ33710807-876AAA1A-E9D2-4247-B5F1-D200892EB23CQ33878967-261E2D45-368E-4BF8-A1D1-50967CC41DD4Q33899492-7C650FBD-2261-44F1-A39D-FC2F3839FC55Q34042695-57F6DC10-3AF4-4ADF-A03A-F1625E1E233CQ34212591-5344E35F-BD98-4455-9745-44E269D30769Q34233126-A4A8C220-1B80-4120-9C9C-BF62941CBE08Q34313840-2B9A505D-F465-4C05-8691-8DD91297A218Q34597685-B68615EA-6615-4A52-A4EC-2C0BE3524441Q34762033-5A0BCEB0-B29B-4B2E-9686-C44E6818A0ACQ34893991-F2D69483-1823-41AC-831B-0F8331369C56Q34915365-44D3DCDF-F07D-4AF7-BBB7-9CBE79A52B86Q34980689-6BAFA44C-866A-48C1-B077-F81FA6CCEBA4Q35150890-7CD2519C-D39C-4C21-B646-7143117C6811Q35167359-08B64D83-986B-404C-9019-97EFEE40B272Q35193871-3B1E77D3-1FB1-4962-9530-69A1A231AB97Q35205390-806F960F-CB91-4378-B567-4EAA044297A7Q35414220-1C887114-EB72-4B25-B28F-6F9D48B41FC3Q35618798-22121474-1D18-4891-BDDA-CBD5406DB331Q35745161-FF3381A9-38CF-47FC-9092-BD7839D871EDQ36072651-CFCA3E6D-CAF3-46E4-B9B5-7D6088390F17Q36116908-47231F2E-DBE1-4165-B33C-FA540952EA01Q36365633-BEAA03DF-1B1B-44AE-8F34-F529C6255FF1Q36484871-3B1B65FE-ADDF-472A-8599-63318E437012Q36712480-1CF46B7C-4CB6-46BF-B60A-F689E9B84976Q36719185-B50DCB77-5253-4C34-9FEB-1C47DFABFC0EQ36968427-43C9AC24-624C-4C93-B69C-44C39DF26EEAQ36972505-9FA9C408-A8D7-4674-8682-05518D97848AQ36994761-52424FA8-E69F-47D1-B0AD-5C1563AEBE45Q37062911-05D334B2-99FF-45DF-AC11-9B3868B38133
P2860
Interleukin 18 is a primary mediator of the inflammation associated with dextran sulphate sodium induced colitis: blocking interleukin 18 attenuates intestinal damage.
description
2002 nî lūn-bûn
@nan
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
2002年论文
@zh
2002年论文
@zh-cn
name
Interleukin 18 is a primary me ...... attenuates intestinal damage.
@ast
Interleukin 18 is a primary me ...... attenuates intestinal damage.
@en
type
label
Interleukin 18 is a primary me ...... attenuates intestinal damage.
@ast
Interleukin 18 is a primary me ...... attenuates intestinal damage.
@en
prefLabel
Interleukin 18 is a primary me ...... attenuates intestinal damage.
@ast
Interleukin 18 is a primary me ...... attenuates intestinal damage.
@en
P2093
P2860
P356
P1433
P1476
Interleukin 18 is a primary me ...... attenuates intestinal damage.
@en
P2093
G M Westrich
J M J Derry
P V Sivakumar
P2860
P304
P356
10.1136/GUT.50.6.812
P407
P577
2002-06-01T00:00:00Z